Enabling every patient to receive the right therapy at the right time

Today, on average, twenty-five percent of molecular tests fail, not because sequencing isn't good enough, but because the tissue going into the test isn't pure enough. That leads to missed mutations, repeat testing, higher costs for labs, and delayed decisions for patients.

QuantumCyte is a TechMed platform that bridges digital pathology and molecular diagnostics. We use AI-guided pathology to automatically enrich the most relevant cells before molecular analysis. The result is higher-fidelity molecular data from the same tissue, at scale.